Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM
Clinical trial NCT02780024 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02780024
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2021-10-20
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.